Global Amebiasis Industry Research Report, Growth Trends and Competitive Analysis 2018-2025


Report ID : RC-4916 Category : Pharmaceuticals Published Date : Jan-2019
Publisher : S-AND-P Pages : 116 Format : PDF
Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain. 
In 2018, the global Amebiasis market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Amebiasis.
This study researches the market size of Amebiasis, presents the global Amebiasis sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Amebiasis in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Amebiasis for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
This report includes the following manufacturers; we can also add the other companies as you want.
    Dr. Reddy’s Laboratories
    Mission Pharmacal
    Aceto Corporation
    Mylan Pharmaceuticals
    Impax Laboratories
    Pfizer
    Sanofi
    Lupin Pharmaceuticals
    Glenmark Pharmaceuticals
    Sun Pharmaceutical
    Heritage Pharmaceuticals
Market Segment by Product Type
    Metronidazole
    Paromomycin
    Tinidazole
    Other
Market Segment by Application
    Hospital
    Pharmacy
Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Egypt
        South Africa
The study objectives are:
    To analyze and research the global Amebiasis status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
    To present the key Amebiasis manufacturers, capacity, production, revenue, market share, and recent development for key players.
    To split the breakdown data by regions, type, companies and applications.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends, drivers, influence factors in global and regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Amebiasis are as follows:
    History Year: 2013-2018
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
Table of Contents
1 Report Overview
    1.1 Research Scope
    1.2 Major Manufacturers Covered in This Report
    1.3 Market Segment by Type
        1.3.1 Global Amebiasis Market Size Growth Rate by Type
        1.3.2 Metronidazole
        1.3.3 Paromomycin
        1.3.4 Tinidazole
        1.3.5 Other
    1.4 Market Segment by Application
        1.4.1 Global Amebiasis Market Share by Application (2018-2025)
        1.4.2 Hospital
        1.4.3 Pharmacy
    1.5 Study Objectives
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Amebiasis Market Size
        2.1.1 Global Amebiasis Revenue 2013-2025
        2.1.2 Global Amebiasis Sales 2013-2025
    2.2 Amebiasis Growth Rate by Regions
        2.2.1 Global Amebiasis Sales by Regions 2013-2018
        2.2.2 Global Amebiasis Revenue by Regions 2013-2018
2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
3 Market Share by Manufacturers
    3.1 Amebiasis Sales by Manufacturers
        3.1.1 Amebiasis Sales by Manufacturers 2013-2018
        3.1.2 Amebiasis Sales Market Share by Manufacturers 2013-2018
    3.2 Revenue by Manufacturers
        3.2.1 Amebiasis Revenue by Manufacturers (2013-2018)
        3.2.2 Amebiasis Revenue Share by Manufacturers (2013-2018)
        3.2.3 Global Amebiasis Market Concentration Ratio (CR5 and HHI)
    3.3 Amebiasis Price by Manufacturers
    3.4 Key Manufacturers Amebiasis Plants/Factories Distribution and Area Served
    3.5 Date of Key Manufacturers Enter into Amebiasis Market
    3.6 Key Manufacturers Amebiasis Product Offered
    3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Sales and Revenue for Each Type
        4.1.1 Metronidazole Sales and Revenue (2013-2018)
        4.1.2 Paromomycin Sales and Revenue (2013-2018)
        4.1.3 Tinidazole Sales and Revenue (2013-2018)
        4.1.4 Other Sales and Revenue (2013-2018)
    4.2 Global Amebiasis Sales Market Share by Type
    4.3 Global Amebiasis Revenue Market Share by Type
    4.4 Amebiasis Price by Type
5 Market Size by Application
    5.1 Overview
    5.2 Global Amebiasis Sales by Application
6 North America
    6.1 North America Amebiasis Breakdown Data by Company
    6.2 North America Amebiasis Breakdown Data by Type
    6.3 North America Amebiasis Breakdown Data by Application
    6.4 North America Amebiasis Breakdown Data by Countries
        6.4.1 North America Amebiasis Sales by Countries
        6.4.2 North America Amebiasis Revenue by Countries
        6.4.3 United States
        6.4.4 Canada
        6.4.5 Mexico
7 Europe
    7.1 Europe Amebiasis Breakdown Data by Company
    7.2 Europe Amebiasis Breakdown Data by Type
    7.3 Europe Amebiasis Breakdown Data by Application
    7.4 Europe Amebiasis Breakdown Data by Countries
        7.4.1 Europe Amebiasis Sales by Countries
        7.4.2 Europe Amebiasis Revenue by Countries
        7.4.3 Germany
        7.4.4 France
        7.4.5 UK
        7.4.6 Italy
        7.4.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Amebiasis Breakdown Data by Company
    8.2 Asia Pacific Amebiasis Breakdown Data by Type
    8.3 Asia Pacific Amebiasis Breakdown Data by Application
    8.4 Asia Pacific Amebiasis Breakdown Data by Countries
        8.4.1 Asia Pacific Amebiasis Sales by Countries
        8.4.2 Asia Pacific Amebiasis Revenue by Countries
        8.4.3 China
        8.4.4 Japan
        8.4.5 Korea
        8.4.6 India
        8.4.7 Australia
        8.4.8 Indonesia
        8.4.9 Malaysia
        8.4.10 Philippines
        8.4.11 Thailand
        8.4.12 Vietnam
9 Central & South America
    9.1 Central & South America Amebiasis Breakdown Data by Company
    9.2 Central & South America Amebiasis Breakdown Data by Type
    9.3 Central & South America Amebiasis Breakdown Data by Application
    9.4 Central & South America Amebiasis Breakdown Data by Countries
        9.4.1 Central & South America Amebiasis Sales by Countries
        9.4.2 Central & South America Amebiasis Revenue by Countries
        9.4.3 Brazil
10 Middle East and Africa
    10.1 Middle East and Africa Amebiasis Breakdown Data by Type
    10.2 Middle East and Africa Amebiasis Breakdown Data by Application
    10.3 Middle East and Africa Amebiasis Breakdown Data by Countries
        10.3.1 Middle East and Africa Amebiasis Sales by Countries
        10.3.2 Middle East and Africa Amebiasis Revenue by Countries
        10.3.3 GCC Countries
        10.3.4 Egypt
        10.3.5 South Africa
11 Company Profiles
    11.1 Dr. Reddy’s Laboratories
        11.1.1 Dr. Reddy’s Laboratories Company Details
        11.1.2 Company Description and Business Overview
        11.1.3 Sales, Revenue and Market Share of Amebiasis
        11.1.4 Amebiasis Product Introduction
        11.1.5 Dr. Reddy’s Laboratories Recent Development
    11.2 Mission Pharmacal
        11.2.1 Mission Pharmacal Company Details
        11.2.2 Company Description and Business Overview
        11.2.3 Sales, Revenue and Market Share of Amebiasis
        11.2.4 Amebiasis Product Introduction
        11.2.5 Mission Pharmacal Recent Development
    11.3 Aceto Corporation
        11.3.1 Aceto Corporation Company Details
        11.3.2 Company Description and Business Overview
        11.3.3 Sales, Revenue and Market Share of Amebiasis
        11.3.4 Amebiasis Product Introduction
        11.3.5 Aceto Corporation Recent Development
    11.4 Mylan Pharmaceuticals
        11.4.1 Mylan Pharmaceuticals Company Details
        11.4.2 Company Description and Business Overview
        11.4.3 Sales, Revenue and Market Share of Amebiasis
        11.4.4 Amebiasis Product Introduction
        11.4.5 Mylan Pharmaceuticals Recent Development
    11.5 Impax Laboratories
        11.5.1 Impax Laboratories Company Details
        11.5.2 Company Description and Business Overview
        11.5.3 Sales, Revenue and Market Share of Amebiasis
        11.5.4 Amebiasis Product Introduction
        11.5.5 Impax Laboratories Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Company Description and Business Overview
        11.6.3 Sales, Revenue and Market Share of Amebiasis
        11.6.4 Amebiasis Product Introduction
        11.6.5 Pfizer Recent Development
    11.7 Sanofi
        11.7.1 Sanofi Company Details
        11.7.2 Company Description and Business Overview
        11.7.3 Sales, Revenue and Market Share of Amebiasis
        11.7.4 Amebiasis Product Introduction
        11.7.5 Sanofi Recent Development
    11.8 Lupin Pharmaceuticals
        11.8.1 Lupin Pharmaceuticals Company Details
        11.8.2 Company Description and Business Overview
        11.8.3 Sales, Revenue and Market Share of Amebiasis
        11.8.4 Amebiasis Product Introduction
        11.8.5 Lupin Pharmaceuticals Recent Development
    11.9 Glenmark Pharmaceuticals
        11.9.1 Glenmark Pharmaceuticals Company Details
        11.9.2 Company Description and Business Overview
        11.9.3 Sales, Revenue and Market Share of Amebiasis
        11.9.4 Amebiasis Product Introduction
        11.9.5 Glenmark Pharmaceuticals Recent Development
    11.10 Sun Pharmaceutical
        11.10.1 Sun Pharmaceutical Company Details
        11.10.2 Company Description and Business Overview
        11.10.3 Sales, Revenue and Market Share of Amebiasis
        11.10.4 Amebiasis Product Introduction
        11.10.5 Sun Pharmaceutical Recent Development
    11.11 Heritage Pharmaceuticals
12 Value Chain and Sales Channels Analysis
    12.1 Value Chain Analysis
    12.2 Sales Channels Analysis
        12.2.1 Amebiasis Sales Channels
        12.2.2 Amebiasis Distributors
    12.3 Amebiasis Customers
13 Market Forecast
    13.1 Global Amebiasis Sales and Revenue Forecast 2018-2025
    13.2 Global Amebiasis Sales Forecast by Type
    13.3 Global Amebiasis Sales Forecast by Application
    13.4 Amebiasis Forecast by Regions
        13.4.1 Global Amebiasis Sales Forecast by Regions 2018-2025
        13.4.2 Global Amebiasis Revenue Forecast by Regions 2018-2025
    13.5 North America Market Forecast
        13.5.1 North America Amebiasis Forecast by Countries 2018-2025
        13.5.2 United States
        13.5.3 Canada
        13.5.4 Mexico
    13.6 Europe Market Forecast
        13.6.1 Europe Amebiasis Forecast by Countries 2018-2025
        13.6.2 Germany
        13.6.3 France
        13.6.4 UK
        13.6.5 Italy
        13.6.6 Russia
    13.7 Asia Pacific Market Forecast
        13.7.1 Asia Pacific Amebiasis Sales Forecast by Countries 2018-2025
        13.7.2 China
        13.7.3 Japan
        13.7.4 Korea
        13.7.5 India
        13.7.6 Australia
        13.7.7 Indonesia
        13.7.8 Thailand
        13.7.9 Malaysia
        13.7.10 Philippines
        13.7.11 Vietnam
    13.8 Central & South America Market Forecast
        13.8.1 Central & South America Amebiasis Sales Forecast by Countries 2018-2025
        13.8.2 Brazil
    13.9 Middle East and Africa Market Forecast
        13.9.1 Middle East and Africa Amebiasis Sales Forecast by Countries 2018-2025
        13.9.2 GCC Countries
        13.9.3 Egypt
        13.9.4 South Africa
14 Research Findings and Conclusion
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer


Sidebar Menu